Literature DB >> 30738329

Tyrosinase and α-glucosidase inhibitory potential of compounds isolated from Quercus coccifera bark: In vitro and in silico perspectives.

Suat Sari1, Burak Barut2, Arzu Özel3, Ayşe Kuruüzüm-Uz4, Didem Şöhretoğlu5.   

Abstract

Bark of Quercus coccifera is widely used in folk medicine. We tested tyrosinase and α-glucosidase inhibitory effects of Q. coccifera bark extract and isolated compounds from it. The extract inhibited tyrosinase with an IC50 value of 75.13 ± 0.44 µg/mL. Among the isolated compounds, polydatin (6) showed potent tyrosinase inhibition compared to the positive control, kojic acid, with an IC50 value of 4.05 ± 0.30 µg/mL. The Q. coccifera extract also inhibited α-glucosidase significantly with an IC50 value of 3.26 ± 0.08 µg/mL. (-)-8-Chlorocatechin (5) was the most potent isolate, also more potent than the positive control, acarbose, with an IC50 value of 43.60 ± 0.67 µg/mL. According to the kinetic analysis, 6 was a noncompetitive and 5 was a competitive inhibitor of tyrosinase, and 5 was a noncompetitive α-glucosidase inhibitor. In the light of these findings, we performed in silico molecular docking studies for 5 and 6 with QM/MM optimizations to predict their tyrosinase inhibition mechanisms at molecular level and search for correlations with the in vitro results. We found that the ionized form of 5 (5i) showed higher affinity and more stable binding to tyrosinase catalytic site than its neutral form, while 6 bound to the predicted allosteric sites of the enzyme better than the catalytic site.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular modelling; Polydatin; Quercus; Tyrosinase; α-Glucosidase

Mesh:

Substances:

Year:  2019        PMID: 30738329     DOI: 10.1016/j.bioorg.2019.02.015

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  Synthesis and inhibitory activity of N-acetylpyrrolidine derivatives on α-glucosidase and α-amylase.

Authors:  Sompong Sansenya; Chankan Winyakul; Kesinee Nanok; Waya S Phutdhawong
Journal:  Res Pharm Sci       Date:  2020-02-20

2.  New anti-viral drugs for the treatment of COVID-19 instead of favipiravir.

Authors:  Ahmet Aktaş; Burak Tüzün; Rukiye Aslan; Koray Sayin; Hilmi Ataseven
Journal:  J Biomol Struct Dyn       Date:  2020-08-12

Review 3.  Insights on the Inhibitory Power of Flavonoids on Tyrosinase Activity: A Survey from 2016 to 2021.

Authors:  Heba A S El-Nashar; Mariam I Gamal El-Din; Lucian Hritcu; Omayma A Eldahshan
Journal:  Molecules       Date:  2021-12-13       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.